Literature DB >> 1246784

Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.

G R Prout, B Kliman, J J Daly, R A MacLaughlin, P P Griffin, H H Young.   

Abstract

This study was undertaken to determine the effects of DES (diethylstilbestrol) on prostatic neoplasms and of different dosage levels on the pituitary-gonadal axis. It is recommended that when DES is chosen for treatment plasma testosterone be monitored carefully and for long periods of time to evaluate the ability of the dose to achieve levels comparable to castration in each patient.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1246784     DOI： 10.1016/0090-4295(76)90301-0

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  Current concepts in the treatment of genitourinary tract disorders in the older individual.

Authors:  A Atala; M Amin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer.

Authors:  J T Isaacs; N Kyprianou
Journal:  Urol Res       Date:  1987

3.  Steroid receptors in human prostatic cancer a preliminary evaluation.

Authors:  H J de Voogt; P Dingjan
Journal:  Urol Res       Date:  1978

Review 4.  Drug therapy of prostatic cancer.

Authors:  R P Huben; S D Perrapato
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 5.  Hormonal Therapy for Prostate Cancer.

Authors:  Kunal Desai; Jeffrey M McManus; Nima Sharifi
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.